Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2017, Article ID 2105061, 5 pages
https://doi.org/10.1155/2017/2105061
Research Article

Women Living with HIV over Age of 65: Cervical Cancer Screening in a Unique and Growing Population

University of Miami Miller School of Medicine, Department of Obstetrics & Gynecology, Miami, FL, USA

Correspondence should be addressed to Alexandra Aserlind; ude.imaim.dem@dnilresa.a

Received 22 March 2017; Revised 11 May 2017; Accepted 30 July 2017; Published 17 September 2017

Academic Editor: Janet S. Rader

Copyright © 2017 Alexandra Aserlind et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Objective. Women living with HIV are at increased risk of human papillomavirus (HPV) infection, which can lead to cervical cancer. New guidelines recommend indefinite screening. The objective of this study is to describe cervical cancer screening practices and colposcopy results in a cohort of women living with HIV over age of 65 who were followed before the new guidelines. Comorbidities, sexually transmitted infections (STIs), and other risk factors were evaluated. Methods. We conducted a retrospective chart review on 75 women aged 65 or older living with HIV with at least one Pap smear. Results. The mean age of the cohort was 66.5 and at HIV diagnosis was 56. The majority of women were immunocompetent. 80% had serial Pap smears. Of these, 86% of 238 were negative or ASCUS. No women progressed to HSIL. 92% of colposcopies had negative or CIN I results. Three women were treated successfully for high-grade dysplasia. More than half of women had other STIs. 72% were screened for HPV; 50% were positive. Conclusion. The majority of women had negative and low-grade Pap smears. Questions remain regarding the utility of continued Pap screening and the added value of HPV testing in this unique population of older women living with HIV.